Location of Repository

Transmission and accumulation of CTL escape variants drive negative associations between HIV polymorphisms and HLA

By Alasdair Leslie, Daniel Kavanagh, Isobella Honeyborne, Katja Pfafferott, Charles Edwards, Tilly Pillay, Louise Hilton, Christina Thobakgale, Danni Ramduth, Rika Draenert, Sylvie Le Gall, Graz Luzzi, Anne Edwards, Christian Brander, Andrew K. Sewell, Sarah Moore, James Mullins, Corey Moore, Simon Mallal, Nina Bhardwaj, Karina Yusim, Rodney Phillips, Paul Klenerman, Bette Korber, Photini Kiepiela, Bruce Walker and Philip Goulder

Abstract

Human immunodeficiency virus (HIV)-1 amino acid sequence polymorphisms associated with expression of specific human histocompatibility leukocyte antigen (HLA) class I alleles suggest sites of cytotoxic T lymphocyte (CTL)-mediated selection pressure and immune escape. The associations most frequently observed are between expression of an HLA class I molecule and variation from the consensus sequence. However, a substantial number of sites have been identified in which particular HLA class I allele expression is associated with preservation of the consensus sequence. The mechanism behind this is so far unexplained. The current studies, focusing on two examples of “negatively associated” or apparently preserved epitopes, suggest an explanation for this phenomenon: negative associations can arise as a result of positive selection of an escape mutation, which is stable on transmission and therefore accumulates in the population to the point at which it defines the consensus sequence. Such negative associations may only be in evidence transiently, because the statistical power to detect them diminishes as the mutations accumulate. If an escape variant reaches fixation in the population, the epitope will be lost as a potential target to the immune system. These data help to explain how HIV is evolving at a population level. Understanding the direction of HIV evolution has important implications for vaccine development

Topics: Article
Publisher: The Rockefeller University Press
OAI identifier: oai:pubmedcentral.nih.gov:2213090
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Preview

    Citations

    1. (2002). A novel approach to the analysis of specificity, clonality, and frequency of HIV-specific T cell responses reveals a potential mechanism for control of viral escape.
    2. (1998). A very high level of crossreactivity is an essential feature of the T-cell receptor.
    3. (2000). Antigenic drift in the influenza A virus (H3N2) nucleoprotein and escape from recognition by cytotoxic T lymphocytes.
    4. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus.
    5. (2001). Cellular immune responses to HIV.
    6. (1998). Characterization of HLA-B57-restricted human immunodeficiency virus type 1 Gagand RT-specific cytotoxic T lymphocyte responses.
    7. (1997). Co-evolution of human immunodeficiency virus and cytotoxic T-lymphocyte responses.
    8. (2003). Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load.
    9. conserved, and immunodominant cytotoxic T lymphocyte epitopes in slow progressors in HIV type 1 infection.
    10. (2002). Cross-reactive cytotoxic T lymphocytes against a HIV-1 p24 epitope in slow progressors with B*57.
    11. (2004). Cytotoxic T lymphocyte–based control of simian immunodeficiency virus replication in a preclinical AIDS vaccine trial.
    12. (2003). Determinant of HIV-1 mutational escape from cytotoxic T lymphocytes.
    13. (2002). Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level.
    14. (2001). Evolution and transmission of stable CTL escape mutations in HIV infection.
    15. (1999). From TCR engagement to T cell activation: a kinetic view of T cell behavior.
    16. (2003). Gradual adaptation of HIV to human host populations: good or bad news?
    17. (1993). Hemophilia growth and development study. Design, methods, and entry data.
    18. (2004). HIV evolution: CTL escape mutation and reversion after transmission.
    19. (2001). HLA and AIDS: a cautionary tale. Trends Mol.
    20. (2000). HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors.
    21. (1993). HLAA11 epitope loss isolates of Epstein-Barr virus from a highly A11 population.
    22. (1991). Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition.
    23. (1999). Identification of multiple HIV-1 CTL epitopes presented by HLA-B*5101 molecules.
    24. Immune selection for altered antigen processing leads to cytotoxic T lymphocyte escape in chronic HIV-1 infection.
    25. (1996). Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection.
    26. (1998). Lack of strong immune selection pressure by the immunodominant, HLA-A*0201-restricted cytotoxic T lymphocyte response in chronic human immunodeficiency virus-1 infection.
    27. (1997). Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS.
    28. (1989). Longterm culture and fine specificity of human cytotoxic T-lymphocyte clones reactive with human immunodeficiency virus type 1.
    29. (2002). Magnitude and frequency of cytotoxic T-lymphocyte responses: identification of immunodominant regions of human immunodeficiency virus type 1 subtype
    30. (2001). Mother-to-child transmission of HIV infection and CTL escape through HLA-A2-SLYNTVATL epitope sequence variation.
    31. Optimization of the MHC class I peptide cargo is dependent on tapasin.
    32. (1997). Polymorphism in the alpha 1 helix of the HLA-B heavy chain can have an overriding influence on peptide-binding specificity.
    33. (1997). Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection.
    34. (1995). primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens.
    35. (2001). Rapid definition of five novel HLA-A*3002-restricted human immunodeficiency virus-specific cytotoxic T-lymphocyte epitopes by elispot and intracellular cytokine staining assays.
    36. Reversion of CTL escape-variant immunodeficiency viruses in vivo.
    37. (2004). Selection, transmission, and reversion of an antigen-processing
    38. (2001). Substantial differences in specificity of HIV-specific cytotoxic T cells in acute and chronic HIV infection.
    39. (1988). T-cell antigen receptor genes and T-cell recognition.
    40. (2002). The cell biology of MHC class I antigen presentation. Tissue Antigens.
    41. (1995). Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.